Gabriel de Arriba

ORCID: 0000-0001-6626-623X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Blood Pressure and Hypertension Studies
  • Renal function and acid-base balance
  • COVID-19 Clinical Research Studies
  • Potassium and Related Disorders
  • Electrolyte and hormonal disorders
  • Renal and Vascular Pathologies
  • Parathyroid Disorders and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Biomedical Research and Pathophysiology
  • Heart Failure Treatment and Management
  • Nephrotoxicity and Medicinal Plants
  • Ion Transport and Channel Regulation
  • Innovations in Medical Education
  • Hormonal Regulation and Hypertension
  • Pharmacological Effects and Toxicity Studies
  • Health and Medical Education
  • Cardiovascular Syncope and Autonomic Disorders
  • Neurological and metabolic disorders
  • Neurological Complications and Syndromes
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 and healthcare impacts
  • Renal and related cancers

Universidad de Alcalá
2015-2025

Hospital Universitario de Guadalajara
2016-2025

Comunidad de Madrid
2025

Instituto de Investigaciones en Ciencias de la Salud
2023-2024

Sociedad Española de Nefrología
2011-2024

Hospital Universitario Puerto Real
2022

Servicio de Salud de Castilla La Mancha
2021

Hospital Universitario Infanta Leonor
2019

Instituto de Salud Carlos III
2017

Instituto Ramón y Cajal de Investigación Sanitaria
2015

Luuk B. Hilbrands Raphaël Duivenvoorden Priya Vart Casper Franssen Marc H. Hemmelder and 95 more Kitty J. Jager Lyanne M. Kieneker Marlies Noordzij Michelle J. Pena Hanne de Vries David Arroyo Adrian Covic Marta Crespo Éric Goffin Mahmud İslam Ziad A. Massy Núria Montero João Oliveira Ana Roca Muñoz J. Emilio Sánchez-Álvarez Sivakumar Sridharan Rebecca Winzeler Ron T. Gansevoort Jeroen B. van der Net Marie Essig Peggy W G du Buf-Vereijken Betty van Ginneken Nanda Maas Liffert Vogt Brigit C. van Jaarsveld Fréderike J. Bemelman Farah Klingenberg-Salahova Frederiek Heenan‐Vos Marc Vervloet Azam Nurmohamed Daniel Abramowicz Sabine Verhofstede Omar Maoujoud Jana Fialová Edoardo Melilli Àlex Favà Josep M. Cruzado Joy Lips Maaike Hengst Ryszard Gellert Andrzej Rydzewski Daniela G Alferes Ivan Rychlík Elena Zakharova Patrice Max Ambuehl Fanny Lepeytre Clémentine Rabaté Guy Rostoker Sofia Marques Tijana Azasevac Dajana Katičić Marc ten Dam Thilo Krüger S. J. J. Logtenberg Lutz Fricke Adriaan L Zanen Jeroen J P Slebe Delphine Kemlin Jacqueline van de Wetering Jaromír Eiselt Lukáš Kielberger Hala S El-Wakil Samar Abd ElHafeez C Canal Carme Facundo Ana Ramos Alicja Dębska‐Ślizień Nicoline M H Veldhuizen Stylianos Panagoutsos Irina Matceac Ionuţ Nistor Monica Cordos J H M Groeneveld Marjolijn van Buren Fritz Diekmann Ana Cristina Fernandes Maria Ferreira Augusto César Soares dos Santos Carlos Arias-Cabrales Laura Llinàs-Mallol Anna Buxeda Carla Burballa Tàrrega Dolores Redondo‐Pachón María Dolores Arenas Jiménez Julia M. Hofstra Antonio Franco María Luisa Rodríguez-Ferrero Sagrario Balda Manzanos Gabriel de Arriba R. Haridian Sosa Barrios Karlijn Bartelet Erol Demir Daan A M J Hollander Angèle P. M. Kerckhoffs Stefan Büttner Aiko P. J. de Vries

Abstract Background. Patients on kidney replacement therapy comprise a vulnerable population and may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently, only limited data are available outcomes in this patient population. Methods. We set up the ERACODA (European Renal Association COVID-19 Database) database, which is specifically designed to prospectively collect detailed transplant dialysis patients with COVID-19. For analysis, were included who presented...

10.1093/ndt/gfaa261 article EN other-oa Nephrology Dialysis Transplantation 2020-09-25
Miquel Blasco Borja Quiroga José Manuel García‐Aznar Cristina Castro-Alonso Saulo J. Fernández-Granados and 64 more Enrique Luna Gema Fernández Fresnedo Marta Ossorio María Jesús Izquierdo Didier Sánchez-Ospina Laura Castañeda-Infante Ricardo Mouzo Mercedes Cao María Lara Besada-Cerecedo Ricardo Pan-Lizcano Roser Torrá Alberto Ortíz Patricia de Sequera Victoria E Garcia Montemayor Mercedes Salgueira Lazo Auxiliadora Mazuecos Blanca Tamara Jiménez Salcedo María José Espigares Huete Elena Araceli Jiménez Vibora Concepción Álamo Caballero Eduardo Josué Banegas Derás Alejandro Alonso Bethencourt Ángel Alberto García Peña Saulo Fernández Granados Gema Fernández Fresnedo Leonardo Calle García Jesús Martín García Jorge Estifan Kasabji María Jesús Izquierdo Ricardo Mouzo Mirco Rebeca García-Agudo Gabriel de Arriba Carme Facundo Molas Marc Xipell Font Alejandra Yugueros González Paula Antóns Meritxell Ibernon Vilaro Vanessa de la Fuente Fernández Yariel González Galván Antonio Cabezas Cristina Castro Alonso Isabel Juan García Eduardo Garín Cascales J. Morant Enrique Luna Complejo Rosa María Díaz Campillejo Silvia González Sanchidrián Mercedes Cao Vilariño Complejo Milagros Sierra Carpio Mayra Ortega Díaz Rosa Sánchez Hernández Marta Ossorio González Almudena Vega Martínez M Picasso Elena Gomá-Garcés Martín Giorgi Patricia Martínez‐Miguel Eduardo Gutiérrez Martínez Vicente Paraíso Cuevas Rocío Echarri Víctor Martínez Mireia Arnedo L Infante Jose Antonio Menacho Miguel

10.1053/j.ajkd.2024.04.021 article EN American Journal of Kidney Diseases 2024-07-06

Background. Timely referral, preparation and initiation of dialysis remain problematic issues. The purpose this study is to analyse the effect chronic renal disease care education on mode start (planned vs non-planned) modality replacement therapy (RRT).

10.1093/ndt/gfl191 article EN Nephrology Dialysis Transplantation 2006-07-01

Patients with advanced chronic kidney disease (CKD) exhibit higher prevalence of coronary artery calcification (CaC) than general population. CaC has been proposed as a risk factor for mortality in end-stage CKD, but most studies the field are based on short-term follow-up.We conducted cohort, 10-year prospective longitudinal study consecutive cases referred to renal unit. A non-enhanced multislice computed tomography was performed at baseline. assessed by Agatston method. were stratified...

10.1186/s12882-019-1367-1 article EN cc-by BMC Nephrology 2019-05-28

Background. The clinical effectiveness of coronavirus disease 2019 (COVID-19) vaccination in kidney transplant (KT) recipients is lower than the general population. Methods. From April to October 2021, 481 KT with COVID-19, included Spanish Society Nephrology COVID-19 Registry, were analyzed. Data regarding status and vaccine type collected, outcomes unvaccinated or partially vaccinated patients (n = 130) compared fully 351). Results. Clinical picture was similar survival analysis showed no...

10.1097/tp.0000000000004119 article EN Transplantation 2022-04-01

Anticardiolipin antibodies are autoantibodies clinically associated with hypercoagulability. Systemic thrombosis and of the vascular access for haemodialysis coexist immunoregulation abnormalities in end-stage renal disease (ESRD). The aim present study was to analyse incidence thrombotic episodes presence anticardiolipin lupus anticoagulant 73 patients ESRD--51 on 22 conservative treatment. Four (18%) treatment had IgG-anticardiolipin, three them also having anticoagulant. Sixteen (31%)...

10.1093/ndt/6.8.543 article EN Nephrology Dialysis Transplantation 1991-01-01

Patients with Stage 5 chronic kidney disease who are on hemodialysis (HD) remain in a inflammatory state, characterized by the accumulation of uremic toxins that induce endothelial damage and cardiovascular (CVD). Our aim was to examine microvesicles (MVs), monocyte subpopulations, angiopoietins (Ang) identify prognostic markers HD patients or without diabetes mellitus (DM). A total 160 prevalent from 10 centers across Spain were obtained Biobank Nephrology Renal Network (Madrid, Spain): 80...

10.1152/ajprenal.00013.2016 article EN AJP Renal Physiology 2017-01-11

Background. We report an investigation of the effects cyclosporine (CsA) on kidney function, glomerular synthesis reactive oxygen species, peroxidation lipids, and levels thromboxane B2 (TXB2). The effect simultaneous administration antioxidant vitamin E (Vit E) CsA in rats was also evaluated. Methods. Adult male Wistar were treated for 30 days with (30 mg/kg/day), Vit (0.05 mg/ml), plus E, or vehicle used CsA, namely 12.6% ethanol. Results. induced failure increased superoxide anion, H2O2,...

10.1097/00007890-199811270-00011 article EN Transplantation 1998-11-01

In peritoneal dialysis, the appearance of effluent with an abnormal or color is usually a sign serious complication such as peritonitis. other cases, it may be specific event that lacks clinical importance. Even in these mild alarm and concern patients professionals can high.

10.1177/08968608251332715 article EN Peritoneal Dialysis International 2025-04-16

El líquido de diálisis (LD), elemento esencial en la hemodiálisis (HD), se fabrica in situ mezclando 3 componentes: agua tratada, concentrado bicarbonato y ácido. Para evitar precipitación carbonato cálcico magnésico que produce el LD por adición bicarbonato, es necesario añadir un Existen 2 concentrados ácidos según contengan acetato (LDA) o citrato (LDC) como estabilizante. Comparar efecto agudo HD con LDC vs. LDA sobre metabolismo del calcio, fosforo magnesio, equilibrio ácido base,...

10.1016/j.nefro.2018.11.002 article ES cc-by-nc-nd Nefrología 2019-01-25
Carles Forné Serafí Cambray Marcelino Bermúdez-López Elvira Fernández Milica Božić and 95 more José Manuel Valdivielso José Regidor Jaume Almirall Esther Ponz Jesús Arteaga Coloma Auxiliadora Bajo Rubio Raquel Díaz Montserrat Belart Rodríguez Antonio Gascón Jordi Bover Sanjuán Josep Bronsoms Artero J.B. Cabezuelo Jesús Calviño Varela Pilar Caro Acevedo Jordi Carreras Bassa Aleix Cases Elisabet Massó Jiménez Rosario Moreno López Secundino Cigarrán Saray López Prieto Lourdes Comas Mongay Isabel Comerma Teresa Compte Jové Marta Cuberes Izquierdo Fernando de Álvaro Covadonga Hevia Ojanguren Gabriel de Arriba Dolores del Pino Rafael Diaz-Tejeiro Izquierdo Francisco Ahijado Hormigos Marta Dotori Verónica Duarte Sara Estupiñan Torres José Fernández Reyes Loreto Fernández Rodríguez Guillermina Fernández Antonio Galán Serrano César García Cantón Antonio Luis García Herrera Mercedes García Mena Luis Gil Sacaluga María Aguilar José Luis Górriz Emma Huarte Loza José Luis Lerma A. Cañada Jesús Pedro Marín Álvarez Nàdia Martín Alemany Jesús Martín García Alberto Martínez Castelao María Martínez Villaescusa Isabel Martínez Itsaso Larrabide Eguren Silvia Moreno Los Huertos Ricardo Mouzo Mirco Antonia Munar Vila Ana Beatriz Muñoz Díaz Juan F. González Javier Nieto Agustín Carreño Enrique Novoa Fernández Alberto Ortíz Beatriz Fernández Vicente Paraíso Miguel Pérez Fontán Ana Peris Domingo Celestino Piñera Haces D. Garrido Mario Prieto Velasco Carmina Puig Marí Maite Rivera Eduardo Rubio González M. Pilar Ruiz Mercedes Salgueira Lazo Ana Isabel Martínez Puerto José Antonio Sánchez Tomero José Emilio Hernández Sánchez Ramon Sans Lorman Ramón Saracho Maria‐Rosa Sarrias Daniel Serón María José Soler Clara Barrios Fernando Henrique Sousa D Torán Fernando Tornero Molina José Javier Usón Carrasco Ildefonso Valera Cortes Merce Vilaprinyo del Perugia Rafael C Virto Ruiz Vicente Pallarés‐Carratalá C. Santos Altozano Miguel Artigao Ródenas Inés Gil Gil Francisco Adan Gil

Abstract Background Chronic kidney disease (CKD) patients show an increased burden of atherosclerosis and high risk cardiovascular events (CVEs). There are several biomarkers described as being associated with CVEs, but their combined effectiveness in stratification CKD has not been tested. The objective this work is to analyse the ability 19 atheromatous predicting CVEs after 4 years follow-up a subcohort NEFRONA study individuals different stages without previous CVEs. Methods Nineteen...

10.1093/ckj/sfz094 article EN cc-by-nc Clinical Kidney Journal 2019-07-08
Coming Soon ...